In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 26th, 2005 | 25 | Yes |
Popular Name: Olopatadine Hydrochloride Olopatadine Hydrochloride
Find On: PubMed — Wikipedia — Google
CAS Numbers: 113806-05-6 , 140462-76-6 , [140462-76-6]
11-((Z)-3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid
11-((Z)-3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid hydrochloride
11-((Z)-3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid, hydrochloride
11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid
2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid
2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid hydrochloride
CPD000469220; OLOPATADINE HCl; SAM001246802
CPD000469220; OLOPATADINE HYDROCHLORIDE; SAM001246802
Dibenz(b,e)oxepin-2-acetic acid, 11-(3-dimethylamino)propylidene)-6,11-dihydro-, hydrochloride, (Z)-
INN); Olopatadine Hydrochloride (FDA
Olopatadine hydrochloride (Opatanol)
Olopatadine hydrochloride, 98.5%+
Opatanol, Pataday, Patanase, Allelock
{(11Z)-11-[3-(dimethylamino)propylidene]-6,11-dihydrodibenzo[b,e]oxepin-2-yl}acetic acid
{11-[3-Dimethylamino-prop-(Z)-ylidene]-6,11-dihydro-dibenzo[b,e]oxepin-2-yl}-acetic acid
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.26 | 2.06 | -45.27 | 1 | 4 | 0 | 53 | 337.419 | 5 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 3.13e-02 g/l | DrugBank-approved |
biological_use | Antiallergic agent | IBScreen Bioactives IBScreen Bioactives |
Indications | antihistamine | KeyOrganics Bioactives |
mechanism | Histamine H1-receptor antagonist, | IBScreen Bioactives |
Target | Histamine Receptor | Selleck Chemicals |
mechanism | Mediator release inhibitor | IBScreen Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP01210o; 1 hydrogen chloride | NIH Clinical Collection via PubChem |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP01210o; SALT: 1 hydrogen chloride | NIH Clinical Collection via PubChem |
biological_use | Used in the treatment of allergic rhinitis, urticaria, allergic conjunctivitis and asthma | IBScreen Bioactives |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
HRH1-1-E | Histamine H1 Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 16 | 0.44 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
HRH1_CAVPO | P31389 | Histamine H1 Receptor, Guinea Pig | 16 | 0.44 | Binding ≤ 1μM |
HRH1_CAVPO | P31389 | Histamine H1 Receptor, Guinea Pig | 16 | 0.44 | Binding ≤ 10μM |